Identification of genes controlled by the weight-regulating hormone leptin may provide future targets for treating obesity

April 11, 2000

In an article in the April 15 issue of the journal Genes & Development, Jeffrey M. Friedman, Investigator of the Howard Hughes Medical Institute, and his team at The Rockefeller University, provide clues as to how a hormone that regulates body weight works. By scanning thousands of genes from obese mice, they discovered a group of genes that are specifically regulated by the hormone leptin. Obesity is a major health concern in the US. In this country alone, one in five adults suffer from obesity. Studies on how leptin works to control body weight could provide therapeutic targets in the battle of the bulge.

Leptin is produced by fat tissue and secreted into the bloodstream, working its way to the brain and other tissues where it carries out its job by sending a message to stop eating and to burn more fat. Mice that lack leptin are obese, weighing nearly three times more than their normal counterparts. When these obese mice are given hormone treatments, they lose weight in part because they eat less but there is another component to their weight loss that is not known.

To discover why leptin causes additional weight loss, Friedman and colleagues used oligonucleotide microarrays, popularly known as 'gene chips'. These tiny chips, containing thousands of gene fragments, are bathed in a solution containing messenger RNA from two different sources. In this instance, samples were taken from normal mice and mice with little or no natural leptin, after they were treated with the hormone. After mice lacking leptin were given the hormone, their fat cells changed the profile of gene expression in a distinct way, indicating that at least part of the effects of leptin are due to a regulation of gene expression. Many genes appeared that were known to be regulated by a protein named SREBP-1, including SREBP-1 itself. SREBP-1 is known to play a role in controlling fatty acid synthesis. In addition to SREBP-1, other genes involved in fatty acid synthesis were identified. This study demonstrates a link between leptin's action and the regulation of fat tissue mass and body weight. Further work on this important hormone's function may ultimately identify other targets for therapeutic intervention in controlling body weight.
-end-
The reference for the paper is: Alexander Soukas, Paul Cohen, Nicholas D. Socci, and Jeffrey M. Friedman. Leptin-specific patterns of gene expression in white adipose tissue. Genes & Dev. 14: 963--980.

Genes & Development is a top-ranked primary research journal published by Cold Spring Harbor Laboratory Press. The journal publishes research papers and review articles that cover the spectrum of topics in the life sciences. Genes & Development is on the Web and offers full-text access at http://www.genesdev.org.

Cold Spring Harbor Laboratory is a private, nonprofit basic research and educational institution with programs focusing on cancer, neurobiology and plant genetics. Located on the north shore of Long Island, 35 miles from Manhattan, the Laboratory was founded in 1890 as a field station for the study of evolution. It has since developed into a world leader in cancer and molecular biology research. Further information about the Laboratory can be found at http://www.cshl.org.


Cold Spring Harbor Laboratory

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.